Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
77
ASCLF Quote, Financials, Valuation and Earnings
Last price:
$1.7400
Seasonality move
:
285.53%
Day range:
$1.7400 - $1.7400
52-week range:
$0.1753 - $1.9800
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5,185.16x
P/B ratio:
13.86x
Volume:
7K
Avg. volume:
1.5K
1-year change:
892.58%
Market cap:
$1.7B
Revenue:
$178.3K
EPS (TTM):
-$0.04
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Ascletis Pharma, Inc. has -- downside to fair value with a price target of -- per share.
ASCLF vs. S&P 500
-
Over the past 5 trading days, Ascletis Pharma, Inc. has underperformed the S&P 500 by -2.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ascletis Pharma, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ascletis Pharma, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Ascletis Pharma, Inc. reported revenues of --.
Earnings Growth
-
Ascletis Pharma, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Ascletis Pharma, Inc. reported earnings per share of --.
Enterprise value:
1.6B
EV / Invested capital:
--
Price / LTM sales:
5,185.16x
EV / EBIT:
--
EV / Revenue:
4,986.06x
PEG ratio (5yr expected):
-3.39x
EV / Free cash flow:
-66.89x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$2.6M
Return On Assets:
-13.13%
Net Income Margin (TTM):
-10952.61%
Return On Equity:
-13.95%
Return On Invested Capital:
-13.95%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2017-06-30 | 2018-06-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $1.9M | $10M | |
| Gross Profit | -- | -- | $17.4M | $1.9M | $9.4M | |
| Operating Income | -- | -- | -- | -$2.7M | $1M | |
| EBITDA | -- | -- | -- | -$2.5M | $1.3M | |
| Diluted EPS | -- | -- | $0.00 | -$0.00 | $0.00 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $420.9M | $393.2M | $353.7M | $291M | -- | |
| Total Assets | $454.6M | $421.1M | $366.7M | $313.1M | -- | |
| Current Liabilities | $10.3M | $15M | $11.5M | $11.9M | -- | |
| Total Liabilities | $12.2M | $16.2M | $12.5M | $13.2M | -- | |
| Total Equity | $442.4M | $404.8M | $354.2M | $300M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2017-06-30 | 2018-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -$7M | -$1.3M | |
| Cash From Investing | -- | -- | -- | $1.5M | $8.5M | |
| Cash From Financing | -- | -- | -- | $377.4K | -$1.5M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
ASCLF
Sector
Market Cap
$1.7B
$28.5M
Price % of 52-Week High
87.88%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
0.88%
-1.33%
1-Year Price Total Return
892.58%
-20.32%
Beta (5-Year)
-19.271
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.7063
200-day SMA
Buy
Level
$1.2060
Bollinger Bands (100)
Buy
Level
1.1962 - 1.7562
Chaikin Money Flow
Buy
Level
8K
20-day SMA
Buy
Level
$1.5975
Relative Strength Index (RSI14)
Buy
Level
61.7903
ADX Line
Buy
Level
43.5107
Williams %R
Sell
Level
-12.1212
50-day SMA
Buy
Level
$1.3675
MACD (12, 26)
Buy
Level
0.0987
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
224.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.9662)
Buy
CA Score
(Annual)
Level (0.7378)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.7166)
Sell
Piotroski F Score
(Annual)
Level (2)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ascletis Pharma, Inc. engages in the research and development, production, marketing, and sale of pharmaceutical products. The company was founded by Jinzi Jason Wu and is headquartered in Hangzhou, China.
Stock Forecast FAQ
In the current month, ASCLF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ASCLF average analyst price target in the past 3 months is --.
-
Where Will Ascletis Pharma, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ascletis Pharma, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Ascletis Pharma, Inc.?
Analysts are divided on their view about Ascletis Pharma, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ascletis Pharma, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Ascletis Pharma, Inc.'s Price Target?
The price target for Ascletis Pharma, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ASCLF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ascletis Pharma, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ASCLF?
You can purchase shares of Ascletis Pharma, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ascletis Pharma, Inc. shares.
-
What Is The Ascletis Pharma, Inc. Share Price Today?
Ascletis Pharma, Inc. was last trading at $1.7400 per share. This represents the most recent stock quote for Ascletis Pharma, Inc.. Yesterday, Ascletis Pharma, Inc. closed at $1.7400 per share.
-
How To Buy Ascletis Pharma, Inc. Stock Online?
In order to purchase Ascletis Pharma, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ASCLF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ASCLF
Sector
P/E ratio
--
23.75x
PEG ratio
-3.39x
-0.01x
P/B ratio
13.86x
1.83x
Price / LTM sales
5,185.16x
1.60x
Growth Metrics
ASCLF
Sector
Revenue growth
--
4.85%
Earnings growth
--
11.11%
Revenue (5-year growth)
-62.82%
6.45%
Earnings forecast
--
-$0.20
Profitability
ASCLF
Sector
Profitability FY 2024
-$2.8M
$3.6M
Return on invested capital
-13.95%
-30.98%
Return on assets
-13.13%
-27.62%
Return on equity
-13.95%
-36.69%
Earnings Date
Last Earnings Date
Dec
8
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
ASCLF
Sector
Total cash
$266.8M
$27.2M
Short term investments
$148.2M
$25.7M
Total assets
$291.1M
$79.7M
Long term debt
--
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
